StockWatch
·
Healthcare Research- Analytics & Technology
Shareholding10 Aug 2026, 11:20 am

BPC Genesis Fund Sells 2.99% Stake in Indegene Ltd

AI Summary

BPC Genesis Fund I-A SPV Limited has disclosed the sale of its entire holding of 7,190,255 equity shares in Indegene Limited, representing 2.986% of the total share capital. The sale was executed via open market transactions on the NSE (Capital Market Segment) on August 6, 2026. Following the sale, BPC Genesis Fund I-A SPV Limited holds no shares in Indegene Limited. The disclosure was made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Key Highlights

  • BPC Genesis Fund I-A SPV Ltd sold its entire 2.99% stake in Indegene Ltd.
  • The transaction involved 7,190,255 equity shares.
  • Sale was conducted through open market transactions on NSE.
  • The seller now holds 0% stake post-transaction.
  • Disclosure made as per SEBI (SAST) Regulations, 2011.